Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1991 Jun;14(3):218-20.
doi: 10.1093/sleep/14.3.218.

Relative efficacy of drugs for the treatment of sleepiness in narcolepsy

Affiliations
Clinical Trial

Relative efficacy of drugs for the treatment of sleepiness in narcolepsy

M M Mitler et al. Sleep. 1991 Jun.

Abstract

A survey was conducted on 10 polysomnographic studies on the pharmacologic treatment of the sleepiness of narcolepsy. Three studies employed the MSLT and 7 employed the MWT as their polygraphic measure of sleep tendency. Statistically and clinically significant therapeutic changes were apparent for pemoline, modafinil, dextroamphetamine and methylphenidate. Codeine, ritanserin and protriptyline did show statistically significant effects. The common feature among the drugs that did produce clinically significant improvements seems to be facilitatory action on central catecholaminergic transmission. Within this group of drugs, only methylphenidate and dextroamphetamine brought MWT sleep latencies to approximately 70% of normal levels.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Relative efficacy of drugs for treating excessive sleepiness in patients with narcolepsy presented in terms of percent of normal levels of sleepiness (see Methods). The lightest shading denotes baseline values. The intermediate shading denotes treatment values. The darkest shading is used only for the normal values. Abbreviations: GHB = gamma-hydroxybulyrale; COD = codeine; RIT = ritanserin; VIL = viloxazine; PEM = pemoline; MOD = modafinil; PRO = protriptyline; DEX = dextroamphetamine; MET = methylphenidate.

References

    1. Fry JM, Pressman MR, DiPhillipo MA, Forst-Paulus M. Treatment of narcolepsy with codeine. Sleep. 1986;9:269–74. - PubMed
    1. Scrima L, Johnson FH, Thomas EE, Hiller FC. Effects of gamma-hydroxybutyrate (GHB) on multiple sleep latency test (MSLT) in narcolepsy patients: a long term study. Sleep Res. 1990;19:288. - PubMed
    1. Scrima L, Hartman PG, Johnson FH, Thomas EE, Hiller FC. Effects of gamma-hydroxybutyrate (GHB) on sleep of narcolepsy patients: a double-blind study. Sleep. 1990;13(6):479. - PubMed
    1. Lammers GJ, Arends J, Declerck AC, Kamphuisen HAC, Schouwink G, Troost J. Ritanserin, a serotonin 5-HT2 antagonist, reduces daytime sleepiness in narcolepsy (abstract). 10th Congress of The European Sleep Research Society; Strasbourg. 1990. p. 258.
    1. Godbout R, Poirier G, Montplaisir J. New treatments for narcolepsy (viloxazine). Narcolepsy 3rd International Symposium; San Diego. June 1988; pp. 79–81.

Publication types

MeSH terms